Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 and 2 DNA, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex I and II Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Influenzinum
Dosage form
LIQUID
Route
ORAL
Labeler
Deseret Biologicals, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2026-03-26
Substance
HEPATITIS B VIRUS; HERRING SPERM DNA; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
ADENOVIREN NOSODE, CYTOMEGALOVIRUS NOSODE, HERPES SIMPLEX VIRUS 1 AND 2 DNA, EPSTEIN-BARR VIRUS NOSODE, HEPATITIS B NOSODE, HERPES SIMPLEX I AND II NOSODE, HUMAN HERPESVIRUS 6A, HUMAN HERPESVIRUS 6B, INFLUENZINUM